Related Experiment Video
Updated: May 18, 2026
Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
Published on: January 17, 2012
Using a modified yeast two-hybrid system to screen for chemical GEF inhibitors
1Universités Montpellier2 & 1, Montpellier, France.
Abstract:
GTPases of the Ras superfamily act as signaling switches, active when bound to GTP and inactive when bound to GDP. There is now considerable evidence that over-activation of Ras-like pathways participates in the development of many cancer types. In particular, GTPases of the Rho family control cell adhesion, survival, motility, and invasion, cell properties dysregulated in most cancer types. Rho activation is triggered by RhoGEFs, most of which form complexes with growth-factor receptors and initiate downstream Rho signaling pathways in response to extracellular clues. As such, RhoGEFs represent attractive targets to inhibit Rho pathways and may have interesting druggability for cancer therapeutics. Here we describe a procedure derived from the yeast two-hybrid system, in which activation of a mammalian Rho GTPase by its cognate RhoGEF is converted into variation in the yeast growth. The experimental design is thus suitable for identiying RhoGEF inhibitors and has been optimized for medium-throughput screening. The major advantages of this method lie in the direct monitoring of GEF activity in a living organism and the rapid detection of false positive hits.
Insights
This study presents a novel yeast-based assay to screen for inhibitors of Rho Guanine nucleotide Exchange Factors (RhoGEFs). This method directly monitors RhoGEF activity in living cells, aiding cancer therapeutic development.
Area of Science:
- Molecular Biology
- Cell Signaling
- Cancer Therapeutics
Background:
- Ras superfamily GTPases function as molecular switches in cellular signaling.
- Dysregulated Rho GTPase pathways are implicated in cancer progression, affecting cell adhesion, survival, motility, and invasion.
- Rho Guanine nucleotide Exchange Factors (RhoGEFs) activate Rho GTPases and are potential therapeutic targets for cancer.
Purpose of the Study:
- To develop a method for identifying inhibitors of RhoGEFs.
- To enable medium-throughput screening for potential cancer therapeutics targeting Rho pathways.
Main Methods:
- A yeast two-hybrid system-derived procedure was adapted.
- Mammalian Rho GTPase activation by its cognate RhoGEF is converted into a measurable change in yeast growth.
- The system is optimized for medium-throughput screening.
Main Results:
- The developed assay allows for direct monitoring of RhoGEF activity in a living system.
- The method facilitates rapid detection of false positive hits, improving screening efficiency.
- The experimental design is suitable for identifying RhoGEF inhibitors.
Conclusions:
- This yeast-based assay provides a robust platform for discovering RhoGEF inhibitors.
- The method has potential for developing novel cancer therapeutics by targeting Rho signaling pathways.
- Direct monitoring of GEF activity offers advantages for screening accuracy and efficiency.
